Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on July 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Pharmaceutical Supply and Distribution

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412
New
DIBBS
Epinephrine Injector
Solicitation # SPE2D2-26-R-0009
Solicitation SPE2D2-26-R-0009 is a request for proposal issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain for the procurement of Epinephrine 0.3 MG/0.3 ML Injection Auto-Injectors in 2-count boxes. The contract is structured with a base year and two option years, with an estimated annual quantity of 473,905 boxes and a total duration not to exceed five years. This is a lowest price technically acceptable (LPTA) acquisition, where the award will be granted to the responsible offeror who meets all technical requirements and past performance standards while providing the lowest evaluated aggregate price. Proposals must be submitted electronically via the DIBBS portal by November 16, 2026, following an extension from the original November 2 deadline. Technical requirements mandate that all products be FDA approved with a Therapeutic Equivalence Code of A, unless all family group drugs are B rated, and manufactured in compliance with current Good Manufacturing Practices. Strict packaging and labeling standards apply, including a prohibition on glass bottles and a requirement for linear bar code labeling at the unit-of-use level conforming to GS1-128 or HIBC standards. Contractors must ensure delivery to multiple Prime Vendor distribution centers within 15 days of order completion and be ready to fill orders within 45 calendar days of award. The solicitation also incorporates various FAR and DFARS clauses regarding trade agreements, cybersecurity, and the Drug Supply Chain Security Act.
MEDICAL SUPPLY CHAIN FSGB

POSTED

about 4 hours ago

DEADLINE

in 26 days

AI Contract Overview

Show more

The contract entails the supply and delivery of Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 mL, identified by NSN 6505001387347, with a total quantity of 13,000 units distributed across multiple CLINs to military medical facilities. The product must be packaged and labeled in full compliance with U.S. Pharmacopeia standards and all applicable federal regulations, ensuring traceability, safety, and regulatory alignment for use in military healthcare settings. Delivery is specified as FOB Destination, meaning the contractor assumes full responsibility for transit risks and logistics until the shipment arrives at the designated military medical locations, with the primary place of performance listed as Hampton, Virginia, 23665-2040. This is a subcontract under the Department of Defense’s Medical Supply Chain PHARM FSA, classified under NAICS code 325412 for pharmaceutical preparation manufacturing. The solicitation was posted on July 14, 2026, with responses required by July 20, 2026, indicating a tight turnaround for qualified suppliers. The contract does not specify a set-aside type, suggesting it is open to general industry competition. All deliveries must meet military-grade quality and documentation requirements, and the contractor is expected to manage inventory, packaging, labeling, and timely fulfillment to support the operational readiness of military medical units.

General Info

Supply of 13,000 units of Bupivacaine Hydrochloride 0.5% to military facilities, FOB Destination, compliant with USP and federal regulations.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

HAMPTON, VA, 23665-2040, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-26-T-4119.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

BUPIVACAINE HYDROCH

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supply and delivery of Bupivacaine Hydrochloride Injection, USP, 0.5%, 50 mL (NSN 6505001387347) in quantities totaling 13,000 units across multiple CLINs to military medical facilities. Includes packaging, labeling, and FOB Destination delivery.

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS